The ACR has assembled a task force of medical & policy experts to determine the best course of action for ensuring our patients keep access to treatments they need.
The ACR is aware of the emerging concerns surrounding access to needed treatments such as
#MTX
after the recent decision in Dobbs v. Jackson Women’s Health Organization.
or if any initial disruptions are potentially temporary & due to the independent actions of pharmacists trying to figure out what is & isn’t allowed where they practice.